Warren Averett Asset Management, LLC Maxcyte, Inc. Transaction History
Warren Averett Asset Management, LLC
- $9.72 Billion
- Q3 2025
A detailed history of Warren Averett Asset Management, LLC transactions in Maxcyte, Inc. stock. As of the latest transaction made, Warren Averett Asset Management, LLC holds 50,266 shares of MXCT stock, worth $79,420. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,266Holding current value
$79,420% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MXCT
# of Institutions
118Shares Held
71.8MCall Options Held
0Put Options Held
0-
Cadian Capital Management, LP New York, NY8.23MShares$13 Million0.78% of portfolio
-
Mirabella Financial Services LLP London, X08.2MShares$13 Million1.16% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$12.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY6.7MShares$10.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.59MShares$8.83 Million0.0% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $161M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...